Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors.
- Author:
Myong Hoon IHN
1
;
Duck Woo KIM
;
Sukki CHO
;
Heung Kwon OH
;
Sanghoon JHEON
;
Kwhanmien KIM
;
Eun SHIN
;
Hye Seung LEE
;
Jin Haeng CHUNG
;
Sung Bum KANG
Author Information
- Publication Type:Original Article
- Keywords: Pulmonary metastasis; Colorectal neoplasms; Disease-free interval; Metastasectomy
- MeSH: Colorectal Neoplasms*; Disease-Free Survival; Humans; Lymph Nodes; Metastasectomy; Neoplasm Metastasis*; Prospective Studies; Retrospective Studies; Survival Rate*
- From:Cancer Research and Treatment 2017;49(1):104-115
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Prognostic factors in patients with pulmonary metastases (PM) from colorectal cancer (CRC) are still controversial. This study assessed oncologic outcomes and prognostic factors in patients with metachronous PM from CRC. MATERIALS AND METHODS: Between June 2003 and December 2011, 122 patients with CRC underwent curative resection of PM detected at least 4 months after CRC resection. Clinico-pathological factors selected from the prospectively maintained database were analyzed retrospectively. RESULTS: The median disease-free interval (DFI) between resection of the primary tumor and detection of PM was 22.0 months (range, 4 to 85 months). Solitary PM were detected in 77 patients (63.1%), with a median maximal tumor diameter of 12.0 mm (range, 2 to 70 mm). Of 52 patients who underwent mediastinal lymph node (LN) dissection, eight patients had LN involvement. Five-year overall survival and disease-free survival (DFS) rates after initial pulmonary metastasectomy were 66.4% and 50.9%, respectively. DFI, mediastinal LN involvement, and the number and distribution of PM were significantly prognostic factors for DFS. In multivariable analysis DFI ≥ 12 months, solitary lesion, and absence of mediastinal LN involvement were independently prognostic for DFS. Of the 122 patients, 48 patients (39.3%) developed recurrent PM a median 13.0 months after initial pulmonary metastasectomy. Recurrent DFI was independently prognostic of DFS in patients who underwent repeated pulmonary metastasectomy. CONCLUSION: There is a potential survival benefit for patients with metachronous PM from CRC who undergo pulmonary metastasectomy, even those with recurrent PM. Pulmonary metastasectomy should be considered in selected patients, particularly those with longer DFI, solitary lesions, and absence of mediastinal LN involvement.
